AIM: The aim of the present study is to evaluate pathologic changes in the pancreatic parenchyma in an experimental model of acute pancreatitis (AP) following bilio-pancreatic duct ligation. An effort was made to clarify the role of apigenin, a substance that is well-known for its antioxidant and anti-inflammatory role and its likely beneficial activity to the pancreatic parenchyma following AP in rats. MATERIAL AND METHOD: One hundred twenty-six male Wistar rats 3-4 mo old and weighing 220-350 g were used. At time 0, the following groups were randomly assigned: group sham: rats were subjected to virtual surgery; group control: rats were subjected to surgery for induction of AP, by ligation of the bilio-pancreatic duct; group apigenin: rats were subjected to surgery for induction of AP and enteral feeding with apigenin. Pathologic changes of the pancreatic parenchymal and myeloperoxidase activity were measured at predetermined time intervals 6, 12, 24, 48, and 72 h. RESULT: From the pathologic reports, by comparing the control group with the apigenin group, an improvement of pancreatic tissue architecture following apigenin administration was observed. Inflammatory infiltration, edema, ductal dilation, and necrosis were reduced following apigenin administration over time (P = 0.049, P = 0.228, P = 0.387, P = 0.046). Treatment with apigenin significantly reduced the bilio-pancreatic duct ligation and evoked an increase in pancreatic myeloperoxidase activity (P = 0.030). CONCLUSION: Oral apigenin administration in rats, following experimentally induced pancreatitis, seems to protect the pancreatic tissue. Thus, apigenin administration to humans could potentially ameliorate the damages to the pancreas.
AIM: The aim of the present study is to evaluate pathologic changes in the pancreatic parenchyma in an experimental model of acute pancreatitis (AP) following bilio-pancreatic duct ligation. An effort was made to clarify the role of apigenin, a substance that is well-known for its antioxidant and anti-inflammatory role and its likely beneficial activity to the pancreatic parenchyma following AP in rats. MATERIAL AND METHOD: One hundred twenty-six male Wistar rats 3-4 mo old and weighing 220-350 g were used. At time 0, the following groups were randomly assigned: group sham: rats were subjected to virtual surgery; group control: rats were subjected to surgery for induction of AP, by ligation of the bilio-pancreatic duct; group apigenin: rats were subjected to surgery for induction of AP and enteral feeding with apigenin. Pathologic changes of the pancreatic parenchymal and myeloperoxidase activity were measured at predetermined time intervals 6, 12, 24, 48, and 72 h. RESULT: From the pathologic reports, by comparing the control group with the apigenin group, an improvement of pancreatic tissue architecture following apigenin administration was observed. Inflammatory infiltration, edema, ductal dilation, and necrosis were reduced following apigenin administration over time (P = 0.049, P = 0.228, P = 0.387, P = 0.046). Treatment with apigenin significantly reduced the bilio-pancreatic duct ligation and evoked an increase in pancreaticmyeloperoxidase activity (P = 0.030). CONCLUSION: Oral apigenin administration in rats, following experimentally induced pancreatitis, seems to protect the pancreatic tissue. Thus, apigenin administration to humans could potentially ameliorate the damages to the pancreas.
Authors: I Skondras; M Lambropoulou; A Tsaroucha; S Gardikis; G Tripsianis; C Simopoulos; G Vaos Journal: Hippokratia Date: 2015 Jul-Sep Impact factor: 0.471
Authors: Elham Afghani; Stephen J Pandol; Tooru Shimosegawa; Robert Sutton; Bechien U Wu; Santhi Swaroop Vege; Fred Gorelick; Morihisa Hirota; John Windsor; Simon K Lo; Martin L Freeman; Markus M Lerch; Yoshihisa Tsuji; Gil Y Melmed; Wahid Wassef; Julia Mayerle Journal: Pancreas Date: 2015-11 Impact factor: 3.327
Authors: Georgios I Papachristou; Jorge D Machicado; Tyler Stevens; Mahesh Kumar Goenka; Miguel Ferreira; Silvia C Gutierrez; Vikesh K Singh; Ayesha Kamal; Jose A Gonzalez-Gonzalez; Mario Pelaez-Luna; Aiste Gulla; Narcis O Zarnescu; Konstantinos Triantafyllou; Sorin T Barbu; Jeffrey Easler; Carlos Ocampo; Gabriele Capurso; Livia Archibugi; Gregory A Cote; Louis Lambiase; Rakesh Kochhar; Tiffany Chua; Subhash Ch Tiwari; Haq Nawaz; Walter G Park; Enrique de-Madaria; Peter J Lee; Bechien U Wu; Phil J Greer; Mohannad Dugum; Efstratios Koutroumpakis; Venkata Akshintala; Amir Gougol Journal: Ann Gastroenterol Date: 2016-12-01
Authors: Alexandra Tsaroucha; Vasileios Kaldis; Michail Vailas; Dimitrios Schizas; Maria Lambropoulou; Apostolos Papalois; Christina Tsigalou; Apostolos Gaitanidis; Michael Pitiakoudis; Constantinos Simopoulos Journal: Pan Afr Med J Date: 2021-02-05
Authors: Xian-yun Liu; Tao Xu; Wan-shu Li; Jun Luo; Pei-wu Geng; Li Wang; Meng-ming Xia; Meng-chun Chen; Lei Yu; Guo-Xin Hu Journal: Biomed Res Int Date: 2013-11-28 Impact factor: 3.411